• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Interventional Oncology

UCLA Interventional Oncology

UCLA Interventional Oncology
  • Back to Main Radiology
  • About Us
  • Conditions Treated
    • Thorax:
    • Lung Cancer
    • Lung Metastases
    • Mesothelioma
    • Neuro/Head and Neck:
    • Thyroid Masses
    • Other Malignancies
    • Abdomen and Pelvis:
    • Liver Cancer
    • Liver Metastases
    • Renal Cell Carcinoma
    • Adrenal Tumors
    • Prostate Cancer
    • Uterine Fibroids
    • Other
    • Musculoskeletal/Spine
    • Osteoid Osteoma
    • Spinal Metastases
    • Non-spinal Metastases
    • Pain and Palliation:
    • Cancer Related Pain
    • Malignant Pleural Effusion and Ascites
    • Lung Cancer
    • Lung Metastases
    • Mesothelioma
    • Liver Cancer
    • Liver Metastases
    • Prostate Cancer
    • Uterine Fibroids
    • Malignant Pleural Effusions and Ascites
  • Treatments & Procedures
    • Ablative Therapies:
    • Radiofrequency and Microwave (Thermal) Ablation 
    • Cryoablation
    • Irreversible Electroporation
    • Injection Therapies
    • High-intensity Focused Ultrasound (HIFU)
    • Transarterial Therapies:
    • Embolization
    • Chemoembolization
    • Radioembolization
    • Pain Management & Palliation:
    • Peripheral Nerve Blocks
    • Celiac and Other Ganglion Blocks
    • Malignant Pleural Effusion and Ascites Management
    • Radiofrequency and Microwave (Thermal) Ablation
    • Cryoablation
    • Embolization
    • Chemoembolization
    • Radioembolization
  • Schedule an Appointment
  • Clinical Trials
  • Our Expert Team
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Interventional Oncology

Liver Cancer

  1. Home
  2. UCLA Interventional Oncology
  3. Conditions Treated
  4. Liver Cancer

Liver Cancer

Share this

What is hepatocellular carcinoma?

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Primary liver cancer refers to cancer that originates in the liver rather than cancers from other organs that metastasize to the liver (see metastatic liver cancer). HCC can start as a single tumor or as several tumor nodules across the liver.

The most common cause for HCC in the United States is cirrhosis, or liver scarring, and its related causes discussed below in the Risk Factors section. Even without cirrhosis, other conditions such as Hepatitis B can cause HCC.

hepatocellular-carcinoma-1.png
hepatocellular-carcinoma-2.png

Risk Factors

  • Most common in men above age 50
  • Cirrhosis (liver scarring) and its causes:
    • History of alcohol use
    • Hepatitis B or C infection
    • Fatty liver disease
    • Long term inflammation of the liver
    • Hemochromatosis, or iron overload
  • Other types of liver disease
  • Obesity
  • Diabetes

Symptoms

In early stages of the cancer, there are usually no symptoms. If symptoms do occur, they include:

  • Abdominal pain
  • Jaundice, or yellowing of skin and eyes
  • Weight loss
  • Ascites
  • Fatigue
  • Easy bruising or bleeding

Diagnosis and Screening

In addition to a physical examination, laboratory tests and imaging studies may be needed. These tests may also be necessary at regular intervals to detect early cancer if certain risk factors are present. Our physicians may enroll you into such a screening or surveillance program. The tests may include:

  • Ultrasound
  • CT scan
  • MRI
  • Liver function tests
  • Liver biopsy

Treatments

Our physicians are liver specialists in both imaging and minimal invasive therapy. They work in collaboration with the liver surgeons, hepatologists, and liver oncologists to offer treatments either alone or in combination with traditional surgical and medical therapies. Treatment strategy is personalized taking into account individual risk factors and very importantly, the precise extent of tumor and the condition of the underlying liver through imaging assessment. Optimal strategy may include one or a combination of minimal invasive treatments below:

  • Chemoembolization
  • Radioembolization
  • Thermal ablation (microwave and radiofrequency)
  • Tumor injection (ex. ethanol)
  • Others (ex. IRE, immune modulation)

before and after treatment

For More Information:

For more information or to schedule an appointment with one of our IR physicians, please call 310-481-7545.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth